The company said to continue using the affected Quadrox Oxygenator or specified Venous Hardshell Cardiotomy Reservoir devices if they are already in use and monitor patients for any signs of infection.
The oxygenators provide physiological gas during cardiopulmonary bypass procedures and six-hour cardiopulmonary bypass procedures, and the cardiotomy reservoirs store and filter blood during those operations.
If unused, here are the affected products that should be discarded:
- Cardiotomy reservoirs: VKMO 10000-USA and VKMO 11000-USA
- QUADROX-iD: BEQ-HMOD 30000, HMOD 70000 and BEQ-HMOD 70000
- QUADROX-iR: HMO 71100, HMO 70100, BEQ-HMO 71100, HMO 51100, HMO 50100 and BEQ-HMO 51100
- QUADROX-i: HMO 50000, HMO 51000, HMO 70000, HMO 71000, BEQ_HMO 71000, HMO 10000, HMO 11000, HMO 30000 and HMO 31000
The FDA said it is working with Getinge/Maquet to track adverse events.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.